Cresco Labs (CRLBF) recently experienced a downgrade from Canaccord, which revised its rating from a Buy to a Speculative Buy. The price target for the stock wa
Jun 02, 2025 / 12:30PM GMTOperator Good day, and welcome to Cresco Labs first-quarter 2025 earnings conference call. (Operator Instructions) Please note, this e
Cresco Labs (CRLBF) has received a downgrade from Canaccord, which altered its recommendation to Speculative Buy from a previous Buy. The firm has also adjusted
Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of -33.33% and 0.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (”Cresco Labs” or the ”Company”), the industry leader in branded cannabis products with a portfoli
Key Takeaways:
Cresco Labs (CRLBF) reported a net loss of $15 million in Q1 and a 10.1% revenue decrease year-over-year. Analysts forecast significant po
[url="]Cresco Labs Inc.[/url] (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (”Cresco” or ”Company”), announced today that it will file its first quarter interim fi
Key Highlights:
Cresco Labs (CRLBF) shares fell by 9% due to the delay in its Q1 2025 earnings report. Analysts maintain a price target of $3.00, indicat
[url="]Cresco Labs Inc.[/url] (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (”Cresco” or ”Company”) today announced that the earnings call originally scheduled for
Cresco Labs (CRLBF) has postponed its Q1 2025 earnings call, originally set for May 9, 2025. The company aims to hold the call and file its financial st
[url="]Cresco Labs Inc.[/url] (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (”Cresco” or ”Company”), the industry leader in branded cannabis products with a portfo
Cresco Labs Inc. (CSE:CL, OTCQX:CRLBF) will release Q1 2025 financial results on May 9, 2025, before market hours. The company will hold a conference ca